Abstract:Functional differentiation of chromatin structure is essential for the control of gene expression, nuclear architecture, and chromosome stability. Compelling evidence indicates that alterations in chromatin remodeling proteins play an important role in the pathogenesis of human disease. Among these, α-thalassemia mental retardation X-linked protein (ATRX) has recently emerged as a critical factor involved in heterochromatin formation at mammalian centromeres and telomeres as well as facultative heterochromatin on the murine inactive X chromosome. Mutations in human ATRX result in an X-linked neurodevelopmental condition with various degrees of gonadal dysgenesis (ATRX syndrome). Patients with ATRX syndrome may exhibit skewed X chromosome inactivation (XCI) patterns, and ATRX-deficient mice exhibit abnormal imprinted XCI in the trophoblast cell line. Non-random or skewed XCI can potentially affect both the onset and severity of X-linked disease. Notably, failure to establish epigenetic modifications associated with the inactive X chromosome (Xi) results in several conditions that exhibit genomic and chromosome instability such as fragile X syndrome as well as cancer development. Insight into the molecular mechanisms of ATRX function and its interacting partners in different tissues will no doubt contribute to our understanding of the pathogenesis of ATRX syndrome as well as the epigenetic origins of aneuploidy. In turn, this knowledge will be essential for the identification of novel drug targets and diagnostic tools for cancer progression as well as the therapeutic management of global epigenetic changes commonly associated with malignant neoplastic transformation.

Atrx Deficiency Induces Telomere Dysfunction, Endocrine Defects, and Reduced Life Span.

ATRX Tolerates Activity-Dependent Histone H3 Methyl/phos Switching to Maintain Repetitive Element Silencing in Neurons.

Neuronal Death Resulting from Targeted Disruption of the Snf2 Protein ATRX is Mediated by P53

Atrx is Required for Maintenance of the Neuroprogenitor Cell Pool in the Embryonic Mouse Brain

Mosaic Expression of Atrx in the Mouse Central Nervous System Causes Memory Deficits

Loss of Maternal ATRX Results in Centromere Instability and Aneuploidy in the Mammalian Oocyte and Pre-Implantation Embryo

A mouse model of ATRX deficiency with cognitive deficits and autistic traits

Role of ATRX in chromatin structure and function: implications for chromosome instability and human disease

Atrx Deletion in Neurons Leads to Sexually Dimorphic Dysregulation of Mir-137 and Spatial Learning and Memory Deficits.

Genetic Inactivation of ATRX Leads to a Decrease in the Amount of Telomeric Cohesin and Level of Telomere Transcription in Human Glioma Cells

The Chromatin Remodeler ATRX: Role and Mechanism in Biology and Cancer

Inactivation of Hepatic ATRX in Atrx Foxg1cre Mice Prevents Reversal of Aging-Like Phenotypes by Thyroxine

A new mouse model of ATR-X syndrome carrying a common patient mutation exhibits neurological and morphological defects

ATRX Loss Promotes Tumor Growth and Impairs Nonhomologous End Joining DNA Repair in Glioma

Suppression of the alternative lengthening of telomere pathway by the chromatin remodelling factor ATRX

ATR Regulates Neuronal Activity by Modulating Presynaptic Firing.

ATRX loss induces multiple hallmarks of the alternative lengthening of telomeres (ALT) phenotype in human glioma cell lines in a cell line-specific manner

Structural consequences of disease-causing mutations in the ATRX-DNMT3-DNMT3L (ADD) domain of the chromatin-associated protein ATRX

Short Telomeres and Ataxia-Telangiectasia Mutated Deficiency Cooperatively Increase Telomere Dysfunction and Suppress Tumorigenesis

ATRX Promotes Gene Expression by Facilitating Transcriptional Elongation Through Guanine-Rich Coding Regions.

Phosphorylation of 'SDT-like' motifs in ATRX mediates its interaction with the MRN complex and is important for ALT pathway suppression